Sharon H Saydah

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Use of complementary and alternative medicine among adults with chronic diseases: United States 2002
    Sharon H Saydah
    Centers for Disease Control and Prevention, National Center for Health Statistics, Office of Analysis and Epidemiology, Hyattsville, MD, USA
    J Altern Complement Med 12:805-12. 2006
  2. ncbi Abnormal glucose tolerance and the risk of cancer death in the United States
    Sharon H Saydah
    Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Am J Epidemiol 157:1092-100. 2003
  3. ncbi Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    Sharon H Saydah
    US Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD, USA
    JAMA 291:335-42. 2004
  4. ncbi The evidence base for public health informing policy at the Centers for Disease Control and Prevention
    Stephen B Thacker
    Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Prev Med 29:227-33. 2005
  5. ncbi Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004
    Min Tao
    Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA
    Diabetes Care 31:93-5. 2008
  6. ncbi Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample
    Sharon H Saydah
    Social and Scientific Systems, Inc, 8757 Georgia Avenue 12th Floor, Silver Spring, MD, USA
    Diabetes Metab Res Rev 19:202-8. 2003
  7. ncbi Pregnancy experience among women with and without gestational diabetes in the U.S., 1995 National Survey Of Family Growth
    Sharon H Saydah
    National Centers for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    Diabetes Care 28:1035-40. 2005
  8. ncbi Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data
    Sharon H Saydah
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Ann Epidemiol 14:507-16. 2004
  9. ncbi Age and the burden of death attributable to diabetes in the United States
    Sharon H Saydah
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am J Epidemiol 156:714-9. 2002
  10. ncbi Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002
    Catherine C Cowie
    Diabetes Epidemiology Program, National Institute of Diabetes and Digestive and Kidney Diseases NIH, 6707 Democracy Blvd, Rm 691, MSC 5460, Bethesda, MD 20892 5460, USA
    Diabetes Care 29:1263-8. 2006

Detail Information

Publications11

  1. ncbi Use of complementary and alternative medicine among adults with chronic diseases: United States 2002
    Sharon H Saydah
    Centers for Disease Control and Prevention, National Center for Health Statistics, Office of Analysis and Epidemiology, Hyattsville, MD, USA
    J Altern Complement Med 12:805-12. 2006
    ..Use of Complementary and Alternative Medicine (CAM) has increased in recent years...
  2. ncbi Abnormal glucose tolerance and the risk of cancer death in the United States
    Sharon H Saydah
    Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Am J Epidemiol 157:1092-100. 2003
    ..31, 95% CI: 0.48, 3.56) and diabetes (relative hazard = 1.13, 95% CI: 0.49, 2.62). These data suggest that, in the United States, impaired glucose tolerance is an independent predictor for cancer mortality...
  3. ncbi Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    Sharon H Saydah
    US Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD, USA
    JAMA 291:335-42. 2004
    ..18 mmol/L). CONCLUSION: Further public health efforts are needed to control risk factors for vascular disease among individuals with diagnosed diabetes...
  4. ncbi The evidence base for public health informing policy at the Centers for Disease Control and Prevention
    Stephen B Thacker
    Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Prev Med 29:227-33. 2005
    ..As part of a major re-examination of its organization, in 2004, the Centers for Disease Control and Prevention (CDC) assessed the evidence base for the effectiveness of population-based public health intervention programs...
  5. ncbi Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004
    Min Tao
    Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA
    Diabetes Care 31:93-5. 2008
    ..This study investigated the association between dietary intake of polyunsaturated fatty acids (PUFAs) and peripheral neuropathy in the U.S. population...
  6. ncbi Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample
    Sharon H Saydah
    Social and Scientific Systems, Inc, 8757 Georgia Avenue 12th Floor, Silver Spring, MD, USA
    Diabetes Metab Res Rev 19:202-8. 2003
    ..Therefore, to determine if depressive symptoms increased the risk of type 2 diabetes, we conducted longitudinal analyses using data from the NHANES I Epidemiologic Follow-up Survey (NHEFS)...
  7. ncbi Pregnancy experience among women with and without gestational diabetes in the U.S., 1995 National Survey Of Family Growth
    Sharon H Saydah
    National Centers for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    Diabetes Care 28:1035-40. 2005
    ..To compare the pregnancy experience among women with and without gestational diabetes mellitus (GDM) using a nationally representative survey...
  8. ncbi Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data
    Sharon H Saydah
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Ann Epidemiol 14:507-16. 2004
    ..The ability to identify prevalent cases of diagnosed diabetes is crucial to monitoring preventative care practices and health outcomes among persons with diagnosed diabetes...
  9. ncbi Age and the burden of death attributable to diabetes in the United States
    Sharon H Saydah
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am J Epidemiol 156:714-9. 2002
    ..8% for CVD). These data suggest that diabetes accounts for at least 3.6% of all deaths and 5.2% of CVD deaths in US adults. Improvements in diabetes prevention and treatment should produce noticeable effects on US life expectancy...
  10. ncbi Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002
    Catherine C Cowie
    Diabetes Epidemiology Program, National Institute of Diabetes and Digestive and Kidney Diseases NIH, 6707 Democracy Blvd, Rm 691, MSC 5460, Bethesda, MD 20892 5460, USA
    Diabetes Care 29:1263-8. 2006
    ..The purpose of this study was to examine the prevalences of diagnosed and undiagnosed diabetes, and impaired fasting glucose (IFG) in U.S. adults during 1999-2002, and compare prevalences to those in 1988-1994...
  11. ncbi Projected impact of implementing the results of the diabetes prevention program in the U.S. population
    Sharon H Saydah
    Social and Scientific Systems, Silver Spring, Maryland, USA
    Diabetes Care 25:1940-5. 2002
    ..S. population who meet the Diabetes Prevention Program (DPP) criteria for intervention, defined as BMI >/=24 kg/m(2), fasting plasma glucose level 96-125 mg/dl, and 2-h glucose level 140-199 mg/dl in an oral glucose tolerance test (OGTT)...